Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Pfizer could get UK nod for COVID vaccine this week: Telegraph

Ruchika Sharma25 Nov 2020 11:36 AM IST

New Delhi: Britain could give regulatory approval to Pfizer-BioNTech's COVID-19 vaccine this week, even before the United States authorises it, the...

Healthcare focused SaaS startup Zealthix raises USD 1.1 million in seed round

Healthcare Investor Novalis Biotech holds first closing of second healthcare fund

Ruchika Sharma25 Nov 2020 10:00 AM IST

Ghent: Novalis Biotech, an early stage venture capital investor in technologies to revolutionize healthcare, has recently announced the...

Oxford COVID vaccine shows average efficacy of 70 percent: AstraZeneca

Ruchika Sharma24 Nov 2020 2:00 PM IST

"The vaccine can be stored, transported and handled at normal refrigerated conditions for at least six months and administered within existing...

Favipiravir shows significant improvement in COVID clinical cure: Glenmark

Ruchika Sharma24 Nov 2020 1:00 PM IST

Favipiravir is an antiviral medication that works by inhibiting a viral enzyme called RdRP (RNA dependent RNA polymerase), thereby halting the virus's...

Locally developed COVID vaccine could complete trials within 2 months: Dr Harsh Vardhan

Ruchika Sharma24 Nov 2020 12:06 PM IST

New Delhi: Dr Harsh Vardhan, Union Health Minister said that locally-developed COVID-19 vaccine candidate could complete its final trials in a month...

Strides Pharma gets USFDA nod for therapeutically equivalent of Deltasone Tablets

Ruchika Sharma24 Nov 2020 11:04 AM IST

Prednisone belongs to a class of drugs known as corticosteroids and is used as an anti- inflammatory or an immunosuppressant medication.

Vivimed Labs gets approval for 3 ophthalmic, 3 oral liquid suspension products

Ruchika Sharma24 Nov 2020 10:00 AM IST

Mumbai: Vivimed Labs, a niche Specialty Chemicals and Pharmaceuticals company, on Monday said that it has received approvals for 3 ophthalmic products...

Govt looking to provide industrial parks with facilities to grow API, pharmaceutical, nutraceutical industry; Gowda

Ruchika Sharma23 Nov 2020 1:23 PM IST

Delhi: Government is proactively looking to provide industrial parks with facilities to grow API, pharmaceutical and nutraceutical industry, D V...

AstraZeneca discontinues Phase 3 trial of prostate cancer drug Truqap

Astra-Oxford shot is key to escaping Covid for many nations: Bloomberg

Ruchika Sharma23 Nov 2020 1:13 PM IST

The Astra vaccine costs a fraction of the price set by Pfizer and will be manufactured in multiple countries, from India to Brazil.

Sukoon Health to infuse Rs 100 crore for 4 health centres across India by 2023 end

Ruchika Sharma23 Nov 2020 12:38 PM IST

Delhi: Mental healthcare provider Sukoon Health is planning to invest over Rs 100 crore to open four centres in the country by the end of 2023 as part...

Eli Lilly arthritis drug baricitinib in combination with remdesivir gets USFDA okay to treat Covid

Ruchika Sharma22 Nov 2020 11:00 AM IST

New Delhi: The U.S. Food and Drug Administration on Thursday approved the emergency use of Eli Lilly and Co's arthritis drug, baricitinib, in...

USFDA calls for Advisory Committee Meeting on December 10 to discuss Pfizer Covid Vaccine approval

Ruchika Sharma22 Nov 2020 10:45 AM IST

New Delhi: The U.S. Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC)...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok